Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
TANAKA Kentaro Last modified date:2022.04.06



Graduate School
Undergraduate School
Other Organization
Administration Post
Other


E-Mail *Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
Homepage
https://kyushu-u.pure.elsevier.com/en/persons/kentaro-tanaka
 Reseacher Profiling Tool Kyushu University Pure
Phone
092-642-5378
Academic Degree
MD, PhD
Country of degree conferring institution (Overseas)
No
Field of Specialization
Medical Oncology, Respiratory Medicine, Immunology
Total Priod of education and research career in the foreign country
04years03months
Research
Research Interests
  • Development of biomarkers in the treatment of immune checkpoint inhibitors
    keyword : biomarker, immune checkpoint inhibitor, T lymphocyte, metabolite
    2017.09~2023.03.
  • Function of Hippo pathways in non-small cell lung cancer
    keyword : Hippo pathway, non-small cell lung cancer
    2017.04~2023.03.
  • development of new treatment in small-cell lung cancer
    keyword : advanced small cell lung cancer, clinical trials
    2016.04~2025.03.
  • development of new treatment in advanced non-small cell lung cancer
    keyword : advanced non-small cell lung cancer, clinical trials
    2016.04~2025.03.
  • Regulation of immune system in tumor cells by cytokines in the tumor microenvironment
    keyword : tumor cells, immune checkpoint, tumor microenvironment
    2020.01~2022.09.
  • Research for transcription factors specific in small-cell lung cancer.
    keyword : small-cell lung cancer, transcription factor
    2018.04~2020.12.
  • Functional analyses of immune cells in the tumor microenvironment
    keyword : Immunity, tumor microenvironmemt
    2017.10~2019.03.
  • Clinical development of novel treatment for advanced EGFR-mutation positive non-small cell lung cancer
    keyword : lung cancer, novel treatment, clinical trials
    2017.10~2019.12.
Academic Activities
Papers
1. Asahina H, Tanaka K, Morita S, Maemondo M, Seike M, Okamoto I, Oizumi S, Kagamu H, Takahashi K, Kikuchi T, Isobe T, Sugio K, Kobayashi K, A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)
, Clinical Lung Cancer, 2021.03.
2. Yanagihara T, Tanaka K, Matsumoto K, A measuring method for occupancy of immune checkpoint inhibitors in the cell surface, Biochemical and Biophysical Research Communications, 2020.06.
3. Ikematsu Y, Tanaka K, Toyokawa G, Ijichi K, Ando N, Yoneshima Y, Iwama E, Inoue H, Tagawa T, Nakanishi Y, Okamoto I, NEUROD1 is highly expressed in extensive-stage small cell lung cancer and promotes tumor cell migration., Lung Cancer , 2020.08.
4. Ando N, Tanaka K, Otsubo K, Toyokawa G, Ikematsu Y, Ide M, Yoneshima Y, Iwama E, Inoue H, Ijichi K, Tagawa T, Nakanishi Y, Okamoto I, Association of MOB1 Expression with Poor Disease-Free Survival in Individuals with Non–Small Cell Lung Cancer, Thoracic Cancer, 2020.11.
Presentations
1. Kentaro TANAKA, 「Next-generation TKI」, World Conference on Lung Cancer, 2018.10.
Educational
Other Educational Activities
  • 2018.08.